New Zealand markets closed

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
109.14+0.38 (+0.35%)
At close: 4:02PM EDT
109.14 0.00 (0.00%)
After hours: 07:53PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5193.21B
Enterprise value 3266.74B
Trailing P/E 29.55
Forward P/E 17.89
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)3.62
Price/book (mrq)15.37
Enterprise value/revenue 34.96
Enterprise value/EBITDA 715.42

Trading information

Stock price history

Beta (5Y monthly) 0.83
52-week change 329.60%
S&P500 52-week change 333.64%
52-week high 3121.53
52-week low 379.11
50-day moving average 3108.39
200-day moving average 3113.07

Share statistics

Avg vol (3-month) 37.14M
Avg vol (10-day) 35.77M
Shares outstanding 51.77B
Implied shares outstanding 6N/A
Float 81.74B
% held by insiders 10.12%
% held by institutions 168.83%
Shares short (29 Sep 2021) 413.67M
Short ratio (29 Sep 2021) 41.43
Short % of float (29 Sep 2021) 40.77%
Short % of shares outstanding (29 Sep 2021) 40.77%
Shares short (prior month 30 Aug 2021) 413.55M

Dividends & splits

Forward annual dividend rate 45.2
Forward annual dividend yield 44.78%
Trailing annual dividend rate 35.08
Trailing annual dividend yield 34.67%
5-year average dividend yield 44.26
Payout ratio 4134.05%
Dividend date 314 Nov 2021
Ex-dividend date 413 Oct 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin 12.40%
Operating margin (ttm)35.17%

Management effectiveness

Return on assets (ttm)7.94%
Return on equity (ttm)48.86%

Income statement

Revenue (ttm)53.73B
Revenue per share (ttm)30.36
Quarterly revenue growth (yoy)33.90%
Gross profit (ttm)31.75B
Net income avi to common (ttm)6.6B
Diluted EPS (ttm)3.71
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.6B
Total cash per share (mrq)4.87
Total debt (mrq)82.16B
Total debt/equity (mrq)652.34
Current ratio (mrq)0.91
Book value per share (mrq)7.11

Cash flow statement

Operating cash flow (ttm)20.45B
Levered free cash flow (ttm)18.18B